Figure 1.
Effect of SophorOx™ on the liver function test (LFT). Group 1: animals were exercised and no treatment; group 2: animals received SophorOx™ (500 mg·kg−1·b.w); group 3: animals were exercised and received SophorOx™ orally (500 mg·kg−1·b.w). Group 4 (G4): standard control was not exercised and no SophorOx™ was administered. All results were expressed as mean ± SD (n = 6). Data analysis (GraphPad Prism Software Version 7.04, San Diego, CA, USA) was performed using one-way ANOVA followed by Dunnett's test for multiple comparisons. No statistically significant change was observed across the groups.